Abiopharma

🔍 Hu Jean X. (Executive)

Company: ADVANCED MICRO DEVICES INC (AMD)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Acquired 101,698 shares of Common Stock (Direct)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 215,998.00 | transaction_form_type: 4
• Sold 38,996 shares of Common Stock at $514.39 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 177,002.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,023 shares of Common Stock at $514.39 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 175,979.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-15 | Code: H | nature_of_ownership: By Grantor Retained Annuity Trust Hu 2025 GRAT-1 | shares_owned_after: 19,243.00
• Sold 99,100 shares of Performance Stock Units (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4, F4
• Sold 2,598 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,793.00 | transaction_form_type: 4 | Footnotes: F5, F6, F6
• Acquired 10,669 shares of PRSU Award (Derivative)
  Date: 2026-08-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,669.00 | transaction_form_type: 4 | Footnotes: F7, F8, F8
• Acquired 7,113 shares of RSU Award (Derivative)
  Date: 2026-08-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,113.00 | transaction_form_type: 4 | Footnotes: F5, F9, F9

Footnotes:

• F1: The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release and settlement of performance-based restricted stock units ("PRSU").
• F2: The shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the release of restricted stock units ("RSU").
• F3: Each performance-based PRSU represents a contingent right to receive one share of AMD's common stock.
• F4: Reflects shares issued in settlement of PRSUs earned and vested under PRSU award granted on August 9, 2023.
• F5: Each RSU represents a contingent right to receive one share of AMD's common stock.
• F6: The RSUs vest 1/4 on August 15, 2026 and then quarterly thereafter until August 15, 2029.
• F7: Between 0% and 250% of the target number of PRSUs may be earned depending on (a) the return on AMD's stock price relative to the return of each of the component companies comprising the S&P 500 Index, subject to adjustments, over the performance period that begins August 15, 2026 and ends on August 15, 2029 (or, if earlier, the date immediately preceding the effective date of a change of control of AMD), (b) the absolute return on AMD's stock price over the performance period, and (c) the percentage (if any) by which AMD's 2028 fiscal year non-GAAP earnings per share exceeds AMDs 2026 fiscal year non-GAAP earnings per share. Vesting of any earned PRSUs is generally subject to the Reporting Person's continued employment and/or service with AMD through August 15, 2029 (or the one-year anniversary of a change in control, if earlier).
• F8: The actual number of PRSUs that may be earned, if at all, will be determined by the Compensation and Leadership Resources Committee (the "Committee") based on AMD's actual performance with respect to the performance vesting conditions described in footnote 7, above. Earned and vested PRSUs will generally be settled on the later of August 15, 2029, or the date following the Committee's determination of performance.
• F9: The RSUs vest 1/4 on August 15, 2027 and then quarterly thereafter until August 15, 2030.